EphA2-targeting DOPC-encapsulated siRNA

A liposomal formulation consisting of short-interfering RNAs (siRNAs) directed against ephrin type-A receptor 2 (EphA2) and encapsulated into 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) neutral liposomes, with potential antineoplastic activity. Upon internalization, EphA2-targeting DOPC-encapsulated siRNA can hybridize to EphA2 DNA and mRNA, thereby interfering with both the transcription and translation of EphA2, and thus inhibiting tumor cell growth. The cell-surface receptor EphA2, a member of the ephrin family of receptor tyrosine kinases (RTKs) involved in mammalian development, is overexpressed by a variety of different cancer cell types and plays an important role in tumor growth. (NCI Thesaurus)

YOU MAY ALSO LIKE

EPHA2 wt Allele

Human EPHA2 wild-type allele is located within 1p36 and is approximately 32 kb in length. This allele, which encodes ephrin type-A receptor…

EPHA2 Gene

This gene plays a role in development and is upregulated in several breast carcinomas.

EPHA1 wt Allele

Human EPHA1 wild-type allele is located within 7q34 and is approximately 18 kb in length. This allele, which encodes ephrin type-A receptor…

EPHA1 Gene

This gene is involved in the mediation of development in the nervous system.

EPGN wt Allele

Human EPGN wild-type allele is located in the vicinity of 4q13.3 and is approximately 7 kb in length. This allele, which encodes…

EPGN Gene

This gene plays a role in epithelial cell growth.